Global Next Generation Sequencing Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Published - Apr 2019 | Category - Pharma & Healthcare | No. of Pages - 145 | Published By - EMR

Global Next Generation Sequencing (NGS) market is expected to grow significantly from USD 4.93 billion in 2017 to USD 17.44 billion in 2024, at an exponential CAGR of 22.2% from 2018 to 2024.

Factors propelling the growth of next generation sequencing (NGS) market include technological advancements in data integration and cloud computing, growing demand for new scientific research, and strong demand for clinical diagnostic. Moreover, increasing adoption of next generation sequencing technology in various end-user segments and growing investments in research and development is further propelling the market growth.

The ability of Next-generation sequencing (NGS) technology to generate large amount of sequence data in a short time helps in wide range of genetic analysis, and is being rapidly used in advance clinical research. The strong demand of NGS technology is mainly due to its growing applications in chromosome counting, molecular analysis, gene expression profiling, detection of epigenetic changes, and disease detection. NGS technology presents progressive advantages of cost effectiveness, high resolution and accuracy in genetic analysis. With the use of NGS technology, millions of changes in DNA can be detected with a single test and the cause of disease can be determined. Moreover, growing research and development activities in NGS has resulted in increased demand from various end-user segments.

Global Next Generation Sequencing Market Major Key Companies

Illumina, Inc.
Oxford Nanopore Technologies
Pacific Biosciences of California, Inc.
Agilent Technologies, Inc.
GENEWIZ, Inc.
PierianDx.
Eurofins Genomics
10x Genomics
Genomatix AG
QIAGEN
BGI Genomics Co., Ltd.
Macrogen, Inc.
Thermo Fisher Scientific
Others


 

Quick Buy

Latest Publications